The covalent binding between ERp44 and ERO1α may be controlled by modulating ERp44 SUMOylation in adipocytes which provides a viable strategy for addressing obesity and insulin resistance. Here, ERP44 is linked to obesity due to melanocortin 4 receptor deficiency.